ESC 365 - Conclusions and close

Open Access

Conclusions and close

Session: Personalised anticoagulation therapy in eligible patients with atrial fibrillation

Topic: Oral Anticoagulation

Speaker: Doctor J. Weitz (Hamilton, CA)

Sponsored by Daiichi Sankyo

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Jeffrey Weitz

Thrombosis & Atherosclerosis Research Institute (TaARI), Hamilton (Canada)

31 presentations

1 follower

4 more presentations in this session

Welcome and introduction

Speaker: Doctor J. Weitz (Hamilton, CA)

Choose the right anticoagulant for the eligible patient in the right dose

Speaker: Professor H. Heidbuchel (Antwerp, BE)

Challenging clinical scenarios for therapeutic anticoagulation: a practical approach

Speaker: Doctor M. Akao (Kyoto, JP)

Q&A and discussion

Speaker: Doctor J. Weitz (Hamilton, CA) Professor H. Heidbuchel (Antwerp, BE) Doctor M. Akao (Kyoto, JP)

Access the full session

Personalised anticoagulation therapy in eligible patients with atrial fibrillation

Speakers: Doctor J. Weitz, Doctor J. Weitz, Professor H. Heidbuchel, Doctor M. Akao, Doctor J. Weitz...

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources